Provided by Tiger Trade Technology Pte. Ltd.

MediWound

13.88
+0.77005.87%
Post-market: 13.880.00000.00%16:10 EDT
Volume:167.85K
Turnover:2.31M
Market Cap:179.19M
PE:-8.88
High:14.00
Open:13.17
Low:13.17
Close:13.11
52wk High:20.03
52wk Low:12.52
Shares:12.91M
Float Shares:8.75M
Volume Ratio:1.16
T/O Rate:1.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5630
EPS(LYR):-2.0990
ROE:-72.37%
ROA:-28.59%
PB:5.03
PE(LYR):-6.61

Loading ...

MediWound publishes investor presentation on next-generation enzymatic therapies for non-surgical tissue repair

Reuters
·
May 27

MediWound Q1 net loss widens to USD 3 million; revenue drops 62.7% to USD 1.48 million

Reuters
·
May 27

MediWound Q1 EPS $(0.23) Beats $(0.64) Estimate, Sales $1.475M Miss $3.117M Estimate

Benzinga Earnings
·
May 27

BRIEF-MediWound Q1 EPS USD -0.23

Reuters
·
May 27

Mediwound Reports First Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
May 27

Mediwound Q1 Adjusted Ebitda USD -7 Million

THOMSON REUTERS
·
May 27

Mediwound Q1 Revenue USD 1.5 Million VS. Ibes Estimate USD 3.12 Million

THOMSON REUTERS
·
May 27

Mediwound Q1 EPS USD -0.23

THOMSON REUTERS
·
May 27

Mediwound Ltd: Full-Year 2026 Revenue Guidance Reaffirmed at $24-26 Mln

THOMSON REUTERS
·
May 27

MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update

GlobeNewswire
·
May 27

Mediwound Ltd expected to post a loss of 65 cents a share - Earnings Preview

Reuters
·
May 25

MediWound to Report First Quarter 2026 Financial Results

GlobeNewswire
·
May 07

MediWound Shareholders Back Board, Auditor and CEO Bonus at 2026 Annual Meeting

TIPRANKS
·
May 07

MediWound Gains Attention from Wound Care Leaders as EscharEx Takes On Legacy SANTYL in $2.5B Market

TIPRANKS
·
Apr 23

MediWound: EscharEx Phase III Upside and NexoBrid Traction Support Compelling Buy Thesis

TIPRANKS
·
Apr 14

Newly Published U.S. Expert Consensus Aligns with MediWound’s Strategy for Chronic Wound Debridement

GlobeNewswire
·
Apr 13

Analysts Offer Insights on Healthcare Companies: Mediwound (MDWD) and ImmunityBio (IBRX)

TIPRANKS
·
Apr 10

MediWound presents new EscharEx data backing Phase III VALUE trial in venous leg ulcers

Reuters
·
Apr 07

Analysts Offer Insights on Healthcare Companies: Simulations Plus (SLP) and Mediwound (MDWD)

TIPRANKS
·
Apr 06

MediWound says Vericel awarded ten-year contract valued at up to $197M

TIPRANKS
·
Apr 03